News
2016
-
Holdings
Corporate
December 26, 2016
-
Notice Concerning Acquisition of Dr. Program Co., Ltd., Consolidated Subsidiary of KYORIN Holdings, Inc.
-
Holdings
General
November 29, 2016
-
Notice of Change in Status of Major Shareholder
-
Holdings
Investors
October 31, 2016
-
Reference Data
-
Holdings
Investors
October 31, 2016
-
Financial Results for the 2nd Quarter of Fiscal 2016
-
Holdings
Investors
October 24, 2016
-
Notice of Revision of Half-Year Forecasts for the Fiscal Year Ending March 31, 2017
-
Holdings
Corporate
August 2, 2016
-
Notice Concerning Determination of Details of Stock Options (Stock Acquisition Rights)
-
Holdings
Investors
August 1, 2016
-
Reference Data
-
Holdings
Investors
August 1, 2016
-
Financial Results for the 1st Quarter of Fiscal 2016
-
Holdings
Corporate
July 15, 2016
-
Signing of Licensing and Commercialization Agreement Regarding OTC Drug Products in Japan for the Allergy Treatment Claritin
-
Holdings
Corporate
July 5, 2016
-
Taisho Completes Acquisition of 24.50% Shares in Duoc Hau Giang Pharmaceutical JSC
-
Holdings
Corporate
June 29, 2016
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Investors
May 16, 2016
-
Reference Data
-
Holdings
Investors
May 16, 2016
-
Financial Statements for Fiscal 2015
-
Holdings
Products
April 21, 2016
-
Launch of the Agent for Osteoporosis “Bonviva® Tablet 100 mg”
-
Holdings
Corporate
March 9, 2016
-
Status of Stock Buyback on Open Market, End of Buyback Program
-
Holdings
Corporate
March 1, 2016
-
Status of Stock Buyback on Open Market
-
Holdings
Investors
February 3, 2016
-
Reference Data
-
Holdings
Investors
February 3, 2016
-
Financial Results for the 3rd Quarter of Fiscal 2015
-
Holdings
Corporate
February 3, 2016
-
Decision on Matters Concerning Stock Buyback
-
Group Company
Corporate
January 22, 2016
-
Agent for Osteoporosis Approved in Japan “Bonviva® Tablet”
-
Holdings
Products
January 20, 2016
-
Launch of the Transdermal Anti-inflammatory Analgesic Patch Formulation LOQOA® Tape